RS20070185A - Use of androgens to reduce the likelihood of acquiring or to treat skin aging - Google Patents

Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Info

Publication number
RS20070185A
RS20070185A RSP-2007/0185A RSP20070185A RS20070185A RS 20070185 A RS20070185 A RS 20070185A RS P20070185 A RSP20070185 A RS P20070185A RS 20070185 A RS20070185 A RS 20070185A
Authority
RS
Serbia
Prior art keywords
likelihood
loss
acquiring
androgens
reduce
Prior art date
Application number
RSP-2007/0185A
Other languages
English (en)
Inventor
Mohamed El-Alfy
Fernand Labrie
Lamia Azzi
Original Assignee
Endorecherche Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorecherche Inc., filed Critical Endorecherche Inc.,
Publication of RS20070185A publication Critical patent/RS20070185A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Novi postupci tretmana ili umanjenja verovatnoće nastanka bolesti kože koje su rezultat deficijencije androgena povezane sa starošću, posebno atrofije kože, gubitka kolagena, gubitka elastičnih vlakana, gubitka vezivnog tkiva, ce1ulita i nastanka bora, kod podložnih toplokrvnih životinja uključujući ljude, a koji podrazumevaju primenu androgena i/ili prekursora polnog steroida. Takođe su navedeni farmaceutski sastavi za dopremanje aktivnog (ih) sastoj (a) ka koji su korisni prema predmetnom pronalasku.
RSP-2007/0185A 2004-11-01 2005-10-31 Use of androgens to reduce the likelihood of acquiring or to treat skin aging RS20070185A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62411204P 2004-11-01 2004-11-01
PCT/CA2005/001652 WO2006047859A1 (en) 2004-11-01 2005-10-31 Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Publications (1)

Publication Number Publication Date
RS20070185A true RS20070185A (en) 2008-09-29

Family

ID=36318842

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2007/0185A RS20070185A (en) 2004-11-01 2005-10-31 Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Country Status (20)

Country Link
US (1) US20060178352A1 (sr)
EP (1) EP1807062A4 (sr)
JP (1) JP2008517952A (sr)
KR (1) KR20070073964A (sr)
CN (1) CN101094676A (sr)
AP (1) AP2007003982A0 (sr)
AU (1) AU2005301035A1 (sr)
BR (1) BRPI0517950A (sr)
CA (1) CA2585666A1 (sr)
EA (1) EA200700983A1 (sr)
GE (1) GEP20094833B (sr)
HR (1) HRP20070183A2 (sr)
IL (1) IL182844A0 (sr)
MA (1) MA29220B1 (sr)
MX (1) MX2007005098A (sr)
NO (1) NO20072642L (sr)
RS (1) RS20070185A (sr)
TN (1) TNSN07163A1 (sr)
WO (1) WO2006047859A1 (sr)
ZA (1) ZA200703531B (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106038572A (zh) 2004-10-20 2016-10-26 恩多研究公司 性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍
CN101461294B (zh) 2006-06-01 2011-05-18 松下电器产业株式会社 洗衣机用无刷电动机以及搭载其的洗衣机
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
DE112014004733A5 (de) * 2013-10-15 2016-07-14 Chelac Holding Gmbh Steroid-Carbonsäureester, Zusammensetzungen, enthaltend Steroid-Carbonsäureester und Verwendung dieser bei lokal topischer Applikation für kosmetische oder dermatologische Zwecke
RU2699674C1 (ru) * 2015-09-30 2019-09-09 Фуджифилм Корпорэйшн Композиция для чрескожной абсорбции
US20220339176A1 (en) * 2019-09-23 2022-10-27 The Board Of Trustees Of The Leland Stanford Junior University Methods of Treatments to Prolong Gestation and Complications of Menstruation or Gestation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL190146A (sr) * 1953-08-26
ATE275957T1 (de) * 1993-01-19 2004-10-15 Endorech Inc Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
NZ536787A (en) * 1998-06-11 2006-03-31 Endorech Inc Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta diol
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
FR2803750B1 (fr) * 2000-01-17 2004-04-02 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US20030027804A1 (en) * 2001-06-27 2003-02-06 Van Der Hoop Roland Gerritsen Therapeutic combinations for the treatment of hormone deficiencies
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
IL157535A0 (en) * 2003-08-21 2004-03-28 Topimed Ltd Preparations for the prevention of skin atrophy

Also Published As

Publication number Publication date
HRP20070183A2 (en) 2007-08-31
EA200700983A1 (ru) 2008-04-28
AP2007003982A0 (en) 2007-06-30
EP1807062A1 (en) 2007-07-18
CA2585666A1 (en) 2006-05-11
EP1807062A4 (en) 2009-06-03
NO20072642L (no) 2007-07-30
AU2005301035A1 (en) 2006-05-11
TNSN07163A1 (en) 2008-11-21
GEP20094833B (en) 2009-11-25
WO2006047859A1 (en) 2006-05-11
IL182844A0 (en) 2007-09-20
CN101094676A (zh) 2007-12-26
KR20070073964A (ko) 2007-07-10
US20060178352A1 (en) 2006-08-10
BRPI0517950A (pt) 2008-10-21
JP2008517952A (ja) 2008-05-29
MX2007005098A (es) 2008-01-16
MA29220B1 (fr) 2008-02-01
ZA200703531B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
WO2006073786A3 (en) Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
MX2007009368A (es) Metodo para estimular la sintesis de colagena y/o expresion de factor de crecimiento de queratinocitos.
TNSN07163A1 (en) Use of androgens to reduce the likelihood of acquiring or to treat skin aging
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
WO2005105107A3 (en) Hormone treatment of multiple sclerosis
MX2011008616A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
WO2010036947A3 (en) Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
WO2007089454A3 (en) Methods for enhancing skin treatments
TW201129368A (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
MX338512B (es) Dispositivo para tratamiento médico y/o cosmético.
PL2210588T3 (pl) Kompozycje pianotwórcze do leczenia skóry ludzkiej zasadniczo niezawierające aktywnych składników farmaceutycznych
DE60135755D1 (de) Verbindungen und methoden zur behandlung von hautverletzungen
HK1098960A1 (en) Method and composition for treating rhinitis
WO2006086693A3 (en) Medical devices
NZ591037A (en) Wound healing using choroid plexus secreted proteins
EA201270116A1 (ru) Применение лекарственной формы для наружного нанесения, содержащей хитозан
DE502004008793D1 (sr)
RS20070399A (en) Device for the hot-dip coating of a metal strip
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
GB2446341A (en) Method and system for transdermal drug delivery
DE60330888D1 (de) Verwendung von drospirenon zur behandlung von hypertension
TW200511999A (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
NO20071238L (no) Fremgangsmater for leging av skader ved human IL-18 administrering
WO2011015758A3 (fr) Utilisation de n-hexadecanoyl isoleucine comme agent "volumateur" et/ou comme agent "repulpant" de la peau humaine
HK1111924A1 (en) Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient